(P911) Porsche - Ratings and Ratios
Cars, SUVs, Financing, Insurance, Services
Dividends
| Dividend Yield | 4.87% |
| Yield on Cost 5y | 3.04% |
| Yield CAGR 5y | 128.71% |
| Payout Consistency | 100.0% |
| Payout Ratio | 2.2% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 31.7% |
| Value at Risk 5%th | 48.9% |
| Relative Tail Risk | -6.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.53 |
| Alpha | -25.65 |
| CAGR/Max DD | -0.29 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.511 |
| Beta | 0.288 |
| Beta Downside | 0.318 |
| Drawdowns 3y | |
|---|---|
| Max DD | 64.19% |
| Mean DD | 35.31% |
| Median DD | 38.12% |
Description: P911 Porsche December 04, 2025
Dr. Ing. h.c. F. Porsche AG (XETRA:P911) operates a dual-business model that combines premium automobile manufacturing with a suite of financial services-including leasing, dealer financing, insurance brokerage and mobility solutions-across Germany, the broader European market, North America, China and other international regions. The firm, headquartered in Stuttgart, is a wholly-owned subsidiary of Porsche Holding Stuttgart GmbH and has been listed under its current name since November 2009.
In 2023 the company reported revenue of roughly €37 billion and an EBIT margin near 10 %, driven by the delivery of approximately 300 k vehicles and a growing financial services portfolio that now exceeds €10 billion in assets under management. Key economic levers for Porsche include the European Union’s tightening CO₂ emissions regulations, which are accelerating the shift toward electric models, and the prevailing interest-rate environment that directly impacts the profitability of its financing arm.
Sector-wide, the premium-auto segment is being reshaped by the rapid rollout of EV platforms and supply-chain constraints on semiconductor chips, both of which create volatility but also opportunities for firms with strong brand equity and diversified revenue streams like Porsche.
For a deeper quantitative dive, you might explore ValueRay’s analyst dashboard for up-to-date metrics and scenario modeling.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (952.0m TTM) > 0 and > 6% of Revenue (6% = 2.30b TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 1.05pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 14.15% (prev 14.71%; Δ -0.56pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 4.85b > Net Income 952.0m (YES >=105%, WARN >=100%) |
| Net Debt (6.23b) to EBITDA (6.55b) ratio: 0.95 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.35 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (909.0m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 16.45% (prev 26.44%; Δ -9.99pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 72.64% (prev 74.80%; Δ -2.16pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.13 (EBITDA TTM 6.55b / Interest Expense TTM 358.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.60
| (A) 0.10 = (Total Current Assets 21.00b - Total Current Liabilities 15.57b) / Total Assets 53.59b |
| (B) 0.34 = Retained Earnings (Balance) 17.99b / Total Assets 53.59b |
| (C) 0.03 = EBIT TTM 1.48b / Avg Total Assets 52.84b |
| (D) 0.62 = Book Value of Equity 19.22b / Total Liabilities 30.84b |
| Total Rating: 2.60 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 50.28
| 1. Piotroski 5.0pt |
| 2. FCF Yield 4.41% |
| 3. FCF Margin 5.64% |
| 4. Debt/Equity 0.50 |
| 5. Debt/Ebitda 0.95 |
| 6. ROIC - WACC (= -2.87)% |
| 7. RoE 4.09% |
| 8. Rev. Trend -3.26% |
| 9. EPS Trend -81.27% |
What is the price of P911 shares?
Over the past week, the price has changed by -0.98%, over one month by +1.54%, over three months by +9.01% and over the past year by -18.76%.
Is P911 a buy, sell or hold?
What are the forecasts/targets for the P911 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 45.7 | -3.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 50.6 | 6.7% |
P911 Fundamental Data Overview December 11, 2025
Market Cap EUR = 42.81b (42.81b EUR * 1.0 EUR.EUR)
P/E Trailing = 45.1827
P/E Forward = 22.1729
P/S = 1.1153
P/B = 1.9115
P/EG = 1.228
Beta = 1.016
Revenue TTM = 38.38b EUR
EBIT TTM = 1.48b EUR
EBITDA TTM = 6.55b EUR
Long Term Debt = 6.47b EUR (from longTermDebt, last quarter)
Short Term Debt = 4.96b EUR (from shortTermDebt, last quarter)
Debt = 11.43b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.23b EUR (from netDebt column, last quarter)
Enterprise Value = 49.04b EUR (42.81b + Debt 11.43b - CCE 5.20b)
Interest Coverage Ratio = 4.13 (Ebit TTM 1.48b / Interest Expense TTM 358.0m)
FCF Yield = 4.41% (FCF TTM 2.16b / Enterprise Value 49.04b)
FCF Margin = 5.64% (FCF TTM 2.16b / Revenue TTM 38.38b)
Net Margin = 2.48% (Net Income TTM 952.0m / Revenue TTM 38.38b)
Gross Margin = 16.45% ((Revenue TTM 38.38b - Cost of Revenue TTM 32.07b) / Revenue TTM)
Gross Margin QoQ = -1.03% (prev 16.15%)
Tobins Q-Ratio = 0.92 (Enterprise Value 49.04b / Total Assets 53.59b)
Interest Expense / Debt = 3.13% (Interest Expense 358.0m / Debt 11.43b)
Taxrate = 35.95% (-339.0m / -943.0m)
NOPAT = 946.7m (EBIT 1.48b * (1 - 35.95%))
Current Ratio = 1.35 (Total Current Assets 21.00b / Total Current Liabilities 15.57b)
Debt / Equity = 0.50 (Debt 11.43b / totalStockholderEquity, last quarter 22.63b)
Debt / EBITDA = 0.95 (Net Debt 6.23b / EBITDA 6.55b)
Debt / FCF = 2.88 (Net Debt 6.23b / FCF TTM 2.16b)
Total Stockholder Equity = 23.26b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.78% (Net Income 952.0m / Total Assets 53.59b)
RoE = 4.09% (Net Income TTM 952.0m / Total Stockholder Equity 23.26b)
RoCE = 4.97% (EBIT 1.48b / Capital Employed (Equity 23.26b + L.T.Debt 6.47b))
RoIC = 3.15% (NOPAT 946.7m / Invested Capital 30.10b)
WACC = 6.01% (E(42.81b)/V(54.23b) * Re(7.08%) + D(11.43b)/V(54.23b) * Rd(3.13%) * (1-Tc(0.36)))
Discount Rate = 7.08% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 0.14%
[DCF Debug] Terminal Value 78.65% ; FCFE base≈1.92b ; Y1≈1.97b ; Y5≈2.20b
Fair Price DCF = 84.95 (DCF Value 38.69b / Shares Outstanding 455.5m; 5y FCF grow 2.43% → 3.0% )
EPS Correlation: -81.27 | EPS CAGR: -62.63% | SUE: 1.60 | # QB: 1
Revenue Correlation: -3.26 | Revenue CAGR: -3.68% | SUE: -0.74 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.47 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=2.39 | Chg30d=-0.027 | Revisions Net=-4 | Growth EPS=+231.3% | Growth Revenue=+1.5%